• News

"Cancer ‘Vaccine’ Shows Promise in Human Trial of Lymphoma Patients" - Angela La Vito

  • CNBC News
  • New York, NY
  • (April 08, 2019)

An experimental cancer “vaccine” showed promising results in a small clinical trial of patients with lymphoma, according to a study published Monday in the journal Nature Medicine. Researchers at The Mount Sinai Hospital tested the treatment in 11 patients with lymphoma. Their results were successful enough to warrant another clinical trial in March on lymphoma patients as well as breast and head-and-neck cancer. The treatment “has broad implications for multiple types of cancer,” said lead author, Joshua Brody, MD, director of the lymphoma immunotherapy program and assistant professor of medicine, hematology, and medical oncology at the Icahn School of Medicine at Mount Sinai. “This method could also increase the success of other immunotherapies such as checkpoint blockade.”

— Joshua Brody, MD, Assistant Professor, Medicine, Hematology, Medical Oncology, Director, Lymphoma Immunotherapy Program, Icahn School of Medicine at Mount Sinai

Learn more

Additional Coverage: MedicalXpress